Skip to search formSkip to main contentSkip to account menu

Delavirdine:MCnc:Pt:Ser/Plas:Qn

Known as: Délavirdine:Concentration de masse:Temps ponctuel:Sérum/Plasma:Quantitatif, ?????:????:????:??/??:??, Delavirdine:Massa concentratie:Moment:Serum of plasma:Kwantitatief 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2004
2004
OBJECTIVES To investigate different dose combinations of amprenavir and delavirdine in order to assess an optimal dose suitable… 
2000
2000
Delavirdine, a non-nucleoside inhibitor of HIV-1 reverse transcriptase, is metabolized primarily through desalkylation catalyzed… 
1999
1999
Delavirdine is an antiretroviral drug now being used as part of combination antiretroviral therapy for the management of human… 
1998
1998
Four non-nucleoside reverse transcriptase (RT) inhibitors, 9-Cl-TIBO [(+)-S-4,5,6,7-tetrahydro-9-chloro-5-methyl-6-(3-methyl-2… 
Highly Cited
1998
Highly Cited
1998
Administration of delavirdine, an HIV-1 reverse transcriptase inhibitor, to rats or monkeys resulted in apparent loss of hepatic… 
Highly Cited
1997
Highly Cited
1997
1997
1997
Delavirdine mesylate (U-90152T) is a highly specific nonnucleoside HIV-1 reverse transcriptase inhibitor currently under… 
1997
1997
Delavirdine mesylate (U-90152T) is a highly specific nonnucleoside reverse transcriptase inhibitor currently under development… 
1996
1996
  • T. Smart
  • GMHC treatment issues : the Gay Men's Health…
  • 1996
  • Corpus ID: 38558703
For the first time, the Food and Drug Administration (FDA) Antiviral Advisory Committee has not been able to recommend approval…